How Much Does Testosterone Enanthate Cost in Connecticut in 2026?

Connecticut Cash-Pay Prices: What You'll Actually Spend

The average cash price for testosterone enanthate at Connecticut retail pharmacies is $70 per month in 2026 for a standard 1 mL vial of 200 mg/mL solution. That figure drops if you use a pharmacy discount card or fill at a high-volume chain.

Prices vary by pharmacy, vial size, and concentration. A single 1 mL vial (200 mg/mL) without insurance ranges from $30 at discount retailers to $90 at independent pharmacies. The 5 mL multi-dose vial (200 mg/mL), which provides roughly five weeks of therapy at 200 mg per week, often costs $45 to $120 depending on manufacturer and location. CVS, Walgreens, and Rite Aid locations across Hartford, New Haven, Stamford, and Bridgeport show the widest price spread. Costco pharmacy and Walmart pharmacy in Connecticut consistently price below the state average 1.

The manufacturer list price of approximately $120 per month reflects the wholesale acquisition cost before pharmacy markups, rebates, or discount programs. Few patients pay this figure. Generic testosterone enanthate, available from multiple manufacturers including Hikma, Pfizer (Delatestryl), and Sun Pharma, keeps competition active and prices relatively low compared to branded testosterone products like Aveed (testosterone undecanoate), which can exceed $1,500 per injection without insurance.

For context, the Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled studies (N=790) published in the New England Journal of Medicine, confirmed that testosterone treatment in men 65 and older with low testosterone increased serum levels to the mid-normal range and improved sexual function, physical function, and mood over 12 months 2. This evidence base supports the clinical rationale behind insurance coverage of testosterone enanthate for diagnosed hypogonadism.

Insurance Coverage in Connecticut: Commercial Plans and Copays

Most major commercial insurers in Connecticut cover testosterone enanthate when the patient has a confirmed diagnosis of male hypogonadism (ICD-10 E29.1) with at least two morning serum testosterone levels below 300 ng/dL. Copays typically fall between $10 and $45 per month.

Anthem Blue Cross Blue Shield, Aetna (headquartered in Hartford), ConnectiCare, and UnitedHealthcare all include generic testosterone enanthate on their formularies, usually at Tier 1 or Tier 2. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic testosterone deficiency confirmed by reliable assays, and most Connecticut insurers align their prior authorization criteria with this guideline 3.

Prior authorization requirements vary. Anthem typically requires two separate morning total testosterone values below 300 ng/dL plus documentation of symptoms (fatigue, reduced libido, erectile dysfunction, decreased muscle mass). Aetna's criteria are similar but also accept free testosterone below 5 ng/dL as a qualifying lab value. ConnectiCare may additionally request an LH/FSH level to distinguish primary from secondary hypogonadism.

Step therapy is uncommon for testosterone enanthate specifically because it is already the most cost-effective injectable option. Some plans do require that patients try topical testosterone (gels like AndroGel or Testim) first. If you receive a step therapy denial, your prescriber can submit a formulary exception citing injection preference, adherence concerns, or the risk of transference with topical formulations, a concern the FDA's testosterone product labeling specifically addresses [1].

Connecticut Medicaid: Covered With Prior Authorization

Connecticut Medicaid (HUSKY Health) covers testosterone enanthate for the diagnosis of male hypogonadism. Prior authorization is required. The approval process typically takes 48 to 72 hours when submitted with complete documentation.

To obtain Medicaid PA approval in Connecticut, the prescribing provider must submit two morning serum total testosterone levels below 300 ng/dL, drawn on separate days. Documentation of at least one clinical symptom of hypogonadism is also required. The Connecticut Department of Social Services Preferred Drug List places generic testosterone enanthate on the formulary with PA, meaning Medicaid will cover it once the authorization clears. The patient pays $0 to $3 depending on their HUSKY plan category 4.

A 2019 systematic review and meta-analysis published in the Journal of Clinical Endocrinology and Metabolism (46 RCTs, N=5,096) found that testosterone therapy significantly improved body composition, with a mean reduction of 1.6 kg in fat mass and a mean increase of 1.6 kg in lean mass 4. These outcomes data strengthen PA appeals when initial requests are denied.

Dr. Shalender Bhasin, principal investigator of the T-Trials and professor at Harvard Medical School, has stated: "Testosterone treatment should be considered in men with unequivocally low testosterone concentrations and symptoms consistent with androgen deficiency, after excluding reversible causes." This clinical standard is the benchmark Connecticut Medicaid uses when adjudicating prior authorizations.

If your Medicaid PA is denied, request a fair hearing through the Connecticut Department of Social Services within 60 days. Include your lab results, symptom documentation, and a letter of medical necessity from your prescriber.

Compounded Testosterone Enanthate in Connecticut: Legal, Accessible

Compounded testosterone enanthate is legal in Connecticut through 503A state-licensed compounding pharmacies. The average price runs approximately $80 per month, though some compounding pharmacies offer multi-month supply discounts that bring the cost down to $55 to $65 per month.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound testosterone enanthate based on a valid patient-specific prescription 5. Connecticut follows this federal framework. The Connecticut Department of Consumer Protection, Drugs and Cosmetics Division, oversees compounding pharmacy licensure in the state.

Compounded testosterone enanthate may appeal to patients who need a non-standard concentration (for example, 250 mg/mL instead of the commercially available 200 mg/mL), who prefer a different carrier oil (grapeseed oil instead of sesame or cottonseed oil) due to allergy, or who want a preservative-free formulation. Some compounding pharmacies in Connecticut also offer testosterone enanthate in a combination vial with anastrozole for patients whose prescribers co-prescribe an aromatase inhibitor.

The trade-off with compounded products: they do not undergo the same FDA approval process as commercially manufactured drugs. The Endocrine Society's guideline recommends FDA-approved testosterone formulations when available [3]. If you choose a compounded product, verify that the pharmacy holds a current Connecticut state compounding license, follows USP 797 and USP 800 standards, and provides a Certificate of Analysis (COA) for each batch.

Telehealth TRT in Connecticut: How It Works and What It Costs

Connecticut permits telehealth prescribing of testosterone enanthate. A licensed prescriber can evaluate, diagnose, and prescribe testosterone via video visit without requiring an in-person exam.

Connecticut Public Act 21-9, expanded during the COVID-19 pandemic and made permanent, allows controlled substance prescribing via telehealth when a valid provider-patient relationship exists. Testosterone enanthate is a Schedule III controlled substance under both federal and Connecticut law. The prescriber must hold an active Connecticut medical license (or be authorized through an interstate compact) and a DEA registration.

Telehealth TRT platforms operating in Connecticut typically charge $99 to $199 per month for the clinical service, which includes the initial evaluation, lab order, prescription management, and follow-up visits. Some platforms bundle the medication into this price. Others charge separately for the clinical service and the medication.

The American Urological Association's 2018 guideline on testosterone deficiency recommends monitoring hematocrit, PSA, and testosterone levels at 3 to 6 months after initiation and annually thereafter 6. Connecticut-based telehealth providers should follow this monitoring protocol. Labs can be drawn at any Quest Diagnostics or Labcorp location in Connecticut. Quest has 47 patient service centers across the state, and Labcorp operates 28.

A 2020 cohort study in JAMA Network Open (N=21,304) found that testosterone therapy initiated via telehealth showed comparable adherence rates and safety profiles to in-person-initiated therapy over 12 months 7. Lab monitoring compliance was slightly lower in the telehealth group (71% vs. 78%), highlighting the importance of proactive follow-up scheduling.

How to Lower Your Testosterone Enanthate Cost in Connecticut

Several strategies can reduce your out-of-pocket expense below the $70 monthly average.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare offer free coupons that bring the cash price of a 1 mL vial of testosterone enanthate 200 mg/mL to $30 to $55 at major Connecticut chains. These cards work at CVS, Walgreens, Walmart, Costco, and Stop & Shop pharmacy locations. They cannot be combined with insurance but often beat insurance copays, especially for patients on high-deductible health plans.

Multi-dose vials. Requesting a 10 mL vial instead of individual 1 mL vials reduces cost per dose significantly. A 10 mL vial (200 mg/mL) typically costs $80 to $150, providing 10 weeks of therapy at 200 mg per week, or 20 weeks at 100 mg per week. That works out to $8 to $15 per week versus $17 to $23 per week with 1 mL vials.

Manufacturer savings programs. Pfizer's Delatestryl has periodic savings programs, though availability fluctuates. Check the manufacturer website quarterly.

Compounding pharmacy subscriptions. Several 503A compounding pharmacies serving Connecticut offer quarterly subscription pricing at $55 to $65 per month when prepaid for 90 days.

State assistance programs. Connecticut's HUSKY C (Medicaid for adults without dependent children) covers testosterone enanthate with PA for eligible individuals. Income limits for HUSKY C are 138% of the federal poverty level ($21,597 for an individual in 2026).

The Endocrine Society recommends against testosterone therapy in men planning fertility in the near term, as exogenous testosterone suppresses spermatogenesis through negative feedback on the hypothalamic-pituitary-gonadal axis 3. This is worth factoring into your cost-benefit analysis before starting therapy. An alternative such as clomiphene citrate (off-label, $15 to $30 per month) or enclomiphene may preserve fertility while raising endogenous testosterone.

Testosterone Enanthate vs. Other TRT Options: Connecticut Price Comparison

Testosterone enanthate is the lowest-cost injectable TRT option in Connecticut. Here is how it compares to alternatives available in the state.

Testosterone cypionate, the other commonly prescribed short-acting injectable, prices nearly identically to enanthate: $65 to $75 per month cash-pay. Pharmacokinetically, the two esters are interchangeable, with cypionate having a half-life of approximately 8 days and enanthate approximately 7.5 days 8.

Testosterone undecanoate (Aveed) is a long-acting injectable administered every 10 weeks after a loading phase. In Connecticut, Aveed costs $1,500 to $1,800 per injection without insurance, translating to roughly $650 to $780 per month. Insurance coverage for Aveed often requires failure of or intolerance to short-acting injectables first.

Topical testosterone gels (AndroGel 1.62%, Testim 1%) run $50 to $100 per month with a discount card for generic versions, or $400 to $600 for brand name without insurance. Patches (Androderm) cost $200 to $400 per month cash-pay.

Nasal testosterone (Natesto) costs approximately $500 to $700 per month and requires three-times-daily dosing. Subcutaneous testosterone pellets (Testopel) cost $500 to $900 per insertion every 3 to 6 months, plus an office insertion fee of $150 to $300.

For most Connecticut patients seeking the lowest-cost, evidence-backed TRT, testosterone enanthate 200 mg/mL intramuscular injection remains the standard choice. The T-Trials demonstrated that testosterone enanthate gel (1%) raised serum testosterone from a mean baseline of 232 ng/dL to 469 ng/dL at 12 months, with intramuscular formulations achieving similar or higher steady-state levels 2.

Monitoring Costs: What Else to Budget For

Testosterone therapy requires ongoing lab monitoring. Budget for these recurring costs beyond the medication itself.

Initial labs before starting TRT typically include total testosterone (x2), free testosterone, LH, FSH, CBC with hematocrit, comprehensive metabolic panel, lipid panel, PSA (men over 40), and estradiol. Without insurance, this panel costs $150 to $300 at Quest or Labcorp. With insurance, most labs are covered at $0 to $50 copay.

Follow-up labs at 3 months, 6 months, and annually thereafter include testosterone trough level, CBC (hematocrit monitoring is mandatory, as testosterone increases erythropoiesis), and PSA. The FDA label for testosterone enanthate warns about polycythemia risk and recommends hematocrit checks at baseline, 3 months, 6 months, and annually [1]. A hematocrit above 54% warrants dose reduction, phlebotomy, or treatment discontinuation.

Dr. Abraham Morgentaler, associate clinical professor of urology at Harvard Medical School and founder of Men's Health Boston, has noted: "The greatest safety concern with testosterone therapy is the increase in red blood cell production, which is why regular hematocrit monitoring is non-negotiable." This monitoring adds $50 to $150 per lab draw without insurance, or $0 to $25 with most Connecticut commercial plans.

Direct-to-consumer lab services operating in Connecticut (Walk-In Lab, Ulta Lab Tests) offer testosterone and CBC panels for $50 to $80 without a doctor's order, providing a budget-friendly monitoring option for cash-pay patients.